vs

Side-by-side financial comparison of ACCO BRANDS Corp (ACCO) and Healthpeak Properties (DOC). Click either name above to swap in a different company.

Healthpeak Properties is the larger business by last-quarter revenue ($719.4M vs $428.8M, roughly 1.7× ACCO BRANDS Corp). Healthpeak Properties runs the higher net margin — 73.2% vs 5.0%, a 68.2% gap on every dollar of revenue. On growth, Healthpeak Properties posted the faster year-over-year revenue change (3.1% vs -4.3%). Over the past eight quarters, ACCO BRANDS Corp's revenue compounded faster (9.3% CAGR vs 8.9%).

ACCO Brands Corporation is an American multinational company. It was created by the merger of ACCO World from Fortune Brands with General Binding Corporation (GBC). As of 2025, its president and CEO is Thomas W. Tedford.

Healthpeak Properties, Inc. is an American real estate investment trust that invests in real estate related to the healthcare industry including senior housing, life science, and medical offices. It was organized in 2007 in Maryland and headquartered in Denver, Colorado with offices in Irvine, Nashville and San Francisco. As of December 31, 2019, the company owned interests in 617 properties.

ACCO vs DOC — Head-to-Head

Bigger by revenue
DOC
DOC
1.7× larger
DOC
$719.4M
$428.8M
ACCO
Growing faster (revenue YoY)
DOC
DOC
+7.4% gap
DOC
3.1%
-4.3%
ACCO
Higher net margin
DOC
DOC
68.2% more per $
DOC
73.2%
5.0%
ACCO
Faster 2-yr revenue CAGR
ACCO
ACCO
Annualised
ACCO
9.3%
8.9%
DOC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ACCO
ACCO
DOC
DOC
Revenue
$428.8M
$719.4M
Net Profit
$21.3M
$114.0M
Gross Margin
33.6%
Operating Margin
9.3%
17.4%
Net Margin
5.0%
73.2%
Revenue YoY
-4.3%
3.1%
Net Profit YoY
3.4%
2406.4%
EPS (diluted)
$0.23
$0.16

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACCO
ACCO
DOC
DOC
Q4 25
$428.8M
$719.4M
Q3 25
$383.7M
$705.9M
Q2 25
$394.8M
$694.3M
Q1 25
$317.4M
$702.9M
Q4 24
$448.1M
$698.0M
Q3 24
$420.9M
$700.4M
Q2 24
$438.3M
$695.5M
Q1 24
$358.9M
$606.6M
Net Profit
ACCO
ACCO
DOC
DOC
Q4 25
$21.3M
$114.0M
Q3 25
$4.0M
$-117.1M
Q2 25
$29.2M
$31.7M
Q1 25
$-13.2M
$42.8M
Q4 24
$20.6M
$4.5M
Q3 24
$9.3M
$85.9M
Q2 24
$-125.2M
$146.0M
Q1 24
$-6.3M
$6.7M
Gross Margin
ACCO
ACCO
DOC
DOC
Q4 25
33.6%
Q3 25
33.0%
58.6%
Q2 25
32.9%
60.2%
Q1 25
31.4%
61.1%
Q4 24
34.7%
60.3%
Q3 24
32.5%
60.0%
Q2 24
34.8%
60.6%
Q1 24
30.8%
59.8%
Operating Margin
ACCO
ACCO
DOC
DOC
Q4 25
9.3%
17.4%
Q3 25
6.8%
9.2%
Q2 25
8.4%
5.7%
Q1 25
-2.1%
7.7%
Q4 24
9.4%
-2.2%
Q3 24
6.2%
14.1%
Q2 24
-25.4%
22.3%
Q1 24
1.6%
3.7%
Net Margin
ACCO
ACCO
DOC
DOC
Q4 25
5.0%
73.2%
Q3 25
1.0%
-16.6%
Q2 25
7.4%
4.6%
Q1 25
-4.2%
6.1%
Q4 24
4.6%
0.7%
Q3 24
2.2%
12.3%
Q2 24
-28.6%
21.0%
Q1 24
-1.8%
1.1%
EPS (diluted)
ACCO
ACCO
DOC
DOC
Q4 25
$0.23
$0.16
Q3 25
$0.04
$-0.17
Q2 25
$0.31
$0.05
Q1 25
$-0.14
$0.06
Q4 24
$0.21
$0.02
Q3 24
$0.09
$0.12
Q2 24
$-1.29
$0.21
Q1 24
$-0.07
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACCO
ACCO
DOC
DOC
Cash + ST InvestmentsLiquidity on hand
$467.5M
Total DebtLower is stronger
$9.8B
Stockholders' EquityBook value
$664.6M
$7.5B
Total Assets
$2.3B
$20.3B
Debt / EquityLower = less leverage
1.31×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACCO
ACCO
DOC
DOC
Q4 25
$467.5M
Q3 25
$91.0M
Q2 25
$89.4M
Q1 25
$70.6M
Q4 24
$119.8M
Q3 24
$180.4M
Q2 24
$106.9M
Q1 24
$101.8M
Total Debt
ACCO
ACCO
DOC
DOC
Q4 25
$9.8B
Q3 25
$9.1B
Q2 25
$9.0B
Q1 25
$8.9B
Q4 24
$8.7B
Q3 24
$8.6B
Q2 24
$8.6B
Q1 24
$8.8B
Stockholders' Equity
ACCO
ACCO
DOC
DOC
Q4 25
$664.6M
$7.5B
Q3 25
$644.0M
$7.6B
Q2 25
$637.3M
$7.9B
Q1 25
$606.1M
$8.2B
Q4 24
$606.1M
$8.4B
Q3 24
$615.5M
$8.6B
Q2 24
$617.1M
$8.8B
Q1 24
$758.5M
$8.9B
Total Assets
ACCO
ACCO
DOC
DOC
Q4 25
$2.3B
$20.3B
Q3 25
$2.3B
$19.6B
Q2 25
$2.4B
$19.8B
Q1 25
$2.3B
$19.8B
Q4 24
$2.2B
$19.9B
Q3 24
$2.4B
$20.0B
Q2 24
$2.4B
$20.2B
Q1 24
$2.5B
$20.5B
Debt / Equity
ACCO
ACCO
DOC
DOC
Q4 25
1.31×
Q3 25
1.20×
Q2 25
1.14×
Q1 25
1.08×
Q4 24
1.04×
Q3 24
1.00×
Q2 24
0.98×
Q1 24
0.99×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACCO
ACCO
DOC
DOC
Operating Cash FlowLast quarter
$30.6M
$1.3B
Free Cash FlowOCF − Capex
$357.0M
FCF MarginFCF / Revenue
49.6%
Capex IntensityCapex / Revenue
124.4%
Cash ConversionOCF / Net Profit
1.44×
10.99×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACCO
ACCO
DOC
DOC
Q4 25
$30.6M
$1.3B
Q3 25
$71.5M
$315.0M
Q2 25
$-38.9M
$363.5M
Q1 25
$5.5M
$279.4M
Q4 24
$52.7M
$1.1B
Q3 24
$92.9M
$318.2M
Q2 24
$-25.6M
$316.2M
Q1 24
$28.2M
$152.6M
Free Cash Flow
ACCO
ACCO
DOC
DOC
Q4 25
$357.0M
Q3 25
Q2 25
Q1 25
Q4 24
$333.7M
Q3 24
Q2 24
Q1 24
FCF Margin
ACCO
ACCO
DOC
DOC
Q4 25
49.6%
Q3 25
Q2 25
Q1 25
Q4 24
47.8%
Q3 24
Q2 24
Q1 24
Capex Intensity
ACCO
ACCO
DOC
DOC
Q4 25
124.4%
Q3 25
Q2 25
Q1 25
Q4 24
105.6%
Q3 24
Q2 24
Q1 24
Cash Conversion
ACCO
ACCO
DOC
DOC
Q4 25
1.44×
10.99×
Q3 25
17.88×
Q2 25
-1.33×
11.48×
Q1 25
6.52×
Q4 24
2.56×
235.43×
Q3 24
9.99×
3.71×
Q2 24
2.17×
Q1 24
22.85×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ACCO
ACCO

Transferred At Point In Time$421.6M98%
Transferred Over Time$7.2M2%

DOC
DOC

Segment breakdown not available.

Related Comparisons